Collegium Pharmaceutical
COLL
167 hedge funds and large institutions have $575M invested in Collegium Pharmaceutical in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 54 increasing their positions, 48 reducing their positions, and 22 closing their positions.
8,256% more call options, than puts
Call options by funds: $1.34M | Put options by funds: $16K
50% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 22
13% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 48
6% more funds holding
Funds holding: 157 → 167 (+10)
2.17% less ownership
Funds ownership: 107.24% → 105.08% (-2.2%)
11% less capital invested
Capital invested by funds: $646M → $575M (-$71M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$8.07M |
| 2 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$3.53M |
| 3 |
MOACM
Mutual of America Capital Management
New York
|
+$2.41M |
| 4 |
BlackRock
New York
|
+$1.62M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$1.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$7.62M |
| 2 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$5.66M |
| 3 |
Janus Henderson Group
London,
|
-$5.17M |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$4.91M |
| 5 |
Renaissance Technologies
New York
|
-$2.75M |
COLL Hedge Fund Activity: Q3 2022 in Review
167 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q3 2022, worth a combined $575M — down 11% from $646M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new COLL positions and 22 closed out — a net gain of 11 holders — while 54 added to existing stakes and 48 trimmed.
The largest buyer was Millennium Management, adding an estimated $8.07M. The largest seller was Royce & Associates, cutting an estimated $7.62M.
- 167 institutional investors held Collegium Pharmaceutical (COLL) as of Q3 2022, up from 157 in Q2 2022.
- Funds reported $575M of Collegium Pharmaceutical stock for Q3 2022, down 11% quarter-over-quarter.
- 33 funds opened new Collegium Pharmaceutical positions in Q3 2022 and 22 closed out, a net change of +11 holders.
- The largest Collegium Pharmaceutical buyer in Q3 2022 was Millennium Management, an estimated $8.07M added.
- The largest Collegium Pharmaceutical seller in Q3 2022 was Royce & Associates, an estimated $7.62M sold.
Based on aggregated 13F filings for Q3 2022.